205 related articles for article (PubMed ID: 35505474)
1. Trends in rifampicin and isoniazid resistance in patients with presumptive TB.
Palani N; Premkumar M; Vaishnavee V; Dinesh V; Thiruvengadam K; Lavanya J; Sridhar R; Frederick A; Sivaramakrishnan G; Mondal R; Padmapriyadarsini C; Shanmugam S
Int J Tuberc Lung Dis; 2022 May; 26(5):446-453. PubMed ID: 35505474
[No Abstract] [Full Text] [Related]
2. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
Khurana P; Saigal K; Ghosh A
Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
[TBL] [Abstract][Full Text] [Related]
8. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
9. GenoType MTBDRplus assay for screening and characterization of isoniazid and rifampicin resistance-associated mutations in multidrug-resistant Mycobacterium tuberculosis from India.
Sethi S; Yadav R; Singh S; Khaneja R; Aggarwal A; Agarwal P; Behera D
Lett Appl Microbiol; 2017 Nov; 65(5):373-380. PubMed ID: 28793376
[TBL] [Abstract][Full Text] [Related]
10. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
[TBL] [Abstract][Full Text] [Related]
11. Analysis of drug resistance mutations in pulmonary Mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India.
Polu GP; Mohammad Shaik J; Kota NMK; Karumanchi D; Allam US
Braz J Infect Dis; 2019; 23(5):281-290. PubMed ID: 31421108
[TBL] [Abstract][Full Text] [Related]
12. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
Kabir S; Junaid K; Rehman A
Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327
[TBL] [Abstract][Full Text] [Related]
13. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
[TBL] [Abstract][Full Text] [Related]
14. Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay.
Singhal R; Myneedu VP; Arora J; Singh N; Bhalla M; Verma A; Sarin R
Indian J Med Microbiol; 2015 Feb; 33 Suppl():46-52. PubMed ID: 25657156
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
de Vos M; Derendinger B; Dolby T; Simpson J; van Helden PD; Rice JE; Wangh LJ; Theron G; Warren RM
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976588
[TBL] [Abstract][Full Text] [Related]
16. Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
Denkinger CM; Pai M; Dowdy DW
PLoS One; 2014; 9(1):e84197. PubMed ID: 24404155
[TBL] [Abstract][Full Text] [Related]
17. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
Singhal R; Arora J; Sah GC; Bhalla M; Sarin R; Prasad Myneedu V
J Epidemiol Glob Health; 2017 Sep; 7(3):175-180. PubMed ID: 28756826
[TBL] [Abstract][Full Text] [Related]
18. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
[TBL] [Abstract][Full Text] [Related]
20. Rapid Detection of M. tuberculosis and Its Resistance to Rifampicin and Isoniazid with the mfloDx™ MDR-TB test.
Ramasubban G; Michael JS; Gupta R; Venkatesan M; Beauton AP; Hoffner S; Asalapuram P
Int J Mycobacteriol; 2024 Jan; 13(1):91-95. PubMed ID: 38771285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
